One Stop Solution For In-Depth Market Research Reports

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Microfluidics Market

Microfluidics Market by Application (Genomics, Proteomics, Capillary Electrophoresis, IVD (POC, Clinical Diagnostics), Drug Delivery, Microreactor, Lab Tests), Component (Chips, Pump, Needle), Material (Polymer, Glass, Silicon) - Global Forecast to 2023


Product Code : MNMHC00109579
Survey : MarketsandMarkets
Publish On : 20, May, 2022
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD5650 / Question Form
5 User USD6650 / Question Form
Enterprise User USD10000 / Question Form

[Report Description]

“Microfluidics market is projected to grow at a CAGR of 22.6%”
The microfluidics market is projected to reach USD 27.91 billion by 2023 from estimated USD 10.06 billion in 2018, at a CAGR of 22.6%. Quick returns on investment coupled with the fast results and improved portability of the medical equipment embedded with microfluidics technology are the factors expected to drive the market during the forecast period. However, complex and time-consuming regulatory approvals process for the microfluidics technology into existing workflow is one of the factors restraining the growth of this market.

“The in vitro diagnostics application segment is expected to grow at the highest CAGR during the forecast period”
On the basis of application, the microfluidics market is segmented into in vitro diagnostics, pharmaceutical and life science research, drug delivery, and laboratory testing. The in vitro diagnostics segment is expected to witness the highest growth during the forecast period. High prevalence of infectious and lifestyle diseases, relatively lower turnaround times exhibited by POC diagnostics compared to central lab testing methods, rapid rise in aging population, and the introduction of technologically advanced products are some of the key factors driving the growth of the microfluidics market for in vitro diagnostics applications during the forecast period.

“The polymer-based microfluidics segment of microfluidic components market is projected to witness the highest growth during the forecast period“
On the basis of material, the microfluidics component market is segmented into polymer-based microfluidics, glass-based microfluidics, silicone-based microfluidics, and other material-based microfluidics. The polymer-based microfluidics market is expected to witness the highest growth during the forecast period. The high growth rate of this segment is attributed to the greater preference for polymers as a substrate in microfluidic devices among manufacturers, reduced costs, enhanced profit margins, simple manufacturing process, and wider applications in pharmaceutical research, academic laboratories, and molecular diagnostics. Polymers are rapidly evolving and are widely used for various microfluidic devices due to the several benefits associated with their use such as diversity in material properties suitable for particular applications and high flexibility for micro-manufacturing processes.

“Asia Pacific to witness the highest growth during the forecast period”
Asia Pacific is expected to witness the highest growth during the forecast period (2018 to 2023). A number of factors such as low labor and raw material costs, rapidly growing pharmaceutical and biotechnology industries, large population, and growth in investments due to favorable economic conditions (especially in China and India) are responsible for the high growth of the microfluidics market in this region.

Break of primary participants from supply side was as mentioned below:
• By Company Type – Tier 1–53%, Tier 2–26% and Tier 3–21%
• By Designation – C Level–42%, Director Level–26%, Others–32%
• By Region –North America–26%, Europe–35%, Asia Pacific–20%, Latin America- 11%, Middle East and Africa–8%
Some of the major market players in the microfluidics market are Danaher (US), Thermo Fisher (US), PerkinElmer (US), Agilent (US), Bio-Rad (US), Becton, Dickinson and Company (US), Roche (Switzerland), Illumina (US), Fluidigm Microfluidics (US), and QIAGEN (Netherlands). Other key players include Dolomite Microfluidics (UK), GYROS PROTEIN TECHNOLOGIES AB (Sweden), Sphere Fluidics (UK), OPKO Health (US), Waters (US), thinXXS Microtechnology (Germany), Abaxis (US), bioMérieux (France), Abbott (US), Dolomite Microfluidics (UK), Microfluidic ChipShop (Germany), Elveflow (France), Cellix (Ireland), Micronit Microtechnologies (Netherlands), MicroLiquid (Spain), MiniFAB (Australia), uFluidix (Canada), Micralyne (US), and Fluigent (France).
Research Coverage:
The report analyzes the microfluidics market and aims at estimating the market size and future growth potential of this market based on various segments such as application, component, material, and region. The report includes revenue analysis for various application of microfluidics equipment and components across the globe and a competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, SWOT analysis, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a greater share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global microfluidics market. The report analyzes the microfluidics market by application, component, material, and region.
• Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global microfluidics market
• Market Development: Comprehensive information on the lucrative emerging markets by application, component, material, and region
• Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global microfluidics market
• Competitive Assessment: In-depth assessment of growth strategies, product offerings, and capabilities of leading players in the global microfluidics market

TABLE OF CONTENTS

1 INTRODUCTION 18
1.1 OBJECTIVES OF THE STUDY 18
1.2 DEFINITION 18
1.3 SCOPE OF THE STUDY 18
1.3.1 MARKETS COVERED 19
1.4 YEARS CONSIDERED FOR THE STUDY 20
1.5 CURRENCY 20
1.6 LIMITATIONS 20
1.7 STAKEHOLDERS 21
2 RESEARCH METHODOLOGY 22
2.1 RESEARCH DATA 22
2.1.1 SECONDARY DATA 23
2.1.1.1 Key data from secondary sources 23
2.1.2 PRIMARY DATA 24
2.1.2.1 Key data from primary sources 25
2.1.2.2 Key industry insights 26
2.2 MARKET SIZE ESTIMATION 27
2.2.1 BOTTOM-UP APPROACH 28
2.2.2 TOP-DOWN APPROACH 28
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 29
2.4 ASSUMPTIONS FOR THE STUDY 30
3 EXECUTIVE SUMMARY 31
4 PREMIUM INSIGHTS 36
4.1 GROWTH POTENTIAL OF THE MICROFLUIDICS MARKET 36
4.2 ASIA PACIFIC MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL 37
4.3 MICROFLUIDICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 38
4.4 MICROFLUIDICS MARKET, BY GEOGRAPHY 39
4.5 MICROFLUIDICS MARKET: DEVELOPING VS. DEVELOPED COUNTRIES 39
5 MARKET OVERVIEW 40
5.1 INTRODUCTION 40
5.2 MARKET DYNAMICS 40
5.2.1 DRIVERS 41
5.2.1.1 Rising demand for point-of-care testing 41
5.2.1.2 Fast returns on investment 41
5.2.1.3 Faster testing and improved portability through microfluidic chip miniaturization 42
5.2.1.4 Entry of new players and launch of new and advanced products 42
5.2.2 RESTRAINTS 44
5.2.2.1 Complex and time-consuming regulatory approval process 44
5.2.2.2 Incorporation of microfluidics technology into existing workflows 44
5.2.3 OPPORTUNITIES 45
5.2.3.1 Asia as a key growth hotspot 45
5.2.3.2 Expanding applications of drug delivery technologies 45
5.2.3.3 Growing applications of microfluidics technology 46
5.2.4 CHALLENGE 46
5.2.4.1 Standardization/commercialization of microfluidic devices 46
6 INDUSTRY INSIGHTS 48
6.1 INTRODUCTION 48
6.2 INDUSTRY TRENDS 48
6.2.1 SHIFTING TREND TOWARD THE ADOPTION OF POLYMERS 48
6.2.2 UNIVERSITIES ACTIVELY GENERATING MICROFLUIDIC STARTUPS AND LARGE PLAYERS ACQUIRING SMALL PLAYERS 49
6.3 PARENT MARKETS ANALYSIS 51
6.4 EVOLUTION OF MICROFLUIDICS TECHNOLOGY IN HEALTHCARE 55
6.5 VALUE CHAIN ANALYSIS 56
6.5.1 MICROFLUIDIC COMPONENTS PROCUREMENT MODEL OF MAJOR PLAYERS 58
7 MICROFLUIDICS MARKET, BY APPLICATION 59
7.1 INTRODUCTION 60
7.2 IN VITRO DIAGNOSTICS 61
7.2.1 POINT-OF-CARE TESTING 62
7.2.2 CLINICAL DIAGNOSTICS 63
7.3 PHARMACEUTICAL AND LIFE SCIENCE RESEARCH 65
7.3.1 LAB ANALYTICS 67
7.3.1.1 Proteomic analysis 68
7.3.1.2 Genomic analysis 69
7.3.1.3 Cell-based assays 71
7.3.1.4 Capillary electrophoresis 72
7.3.2 MICRODISPENSING 73
7.3.3 MICROREACTION 74
7.4 DRUG DELIVERY 75
7.5 LABORATORY TESTING 77
7.5.1 AGRO FOOD TESTING 78
7.5.2 INDUSTRIAL TESTING 79
7.5.3 ENVIRONMENTAL TESTING 81
8 MICROFLUIDIC COMPONENTS MARKET 82
8.1 MICROFLUIDIC COMPONENTS MARKET, BY TYPE 83
8.1.1 MICROFLUIDIC CHIPS 84
8.1.2 MICROFLUIDIC SENSORS 86
8.1.3 MICROPUMPS 87
8.1.4 MICRONEEDLES 88
8.1.5 OTHER COMPONENTS 89
8.2 MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL 90
8.2.1 POLYMER 91
8.2.2 GLASS 92
8.2.3 SILICON 93
8.2.4 OTHER MATERIALS 94
9 MICROFLUIDICS MARKET, BY REGION 95
9.1 INTRODUCTION 96
9.2 NORTH AMERICA 98
9.2.1 US 103
9.2.2 CANADA 106
9.3 EUROPE 110
9.3.1 GERMANY 115
9.3.2 FRANCE 118
9.3.3 UK 121
9.3.4 ITALY 124
9.3.5 SPAIN 127
9.3.6 REST OF EUROPE 131
9.4 ASIA PACIFIC 135
9.4.1 JAPAN 140
9.4.2 CHINA 143
9.4.3 INDIA 146
9.4.4 REST OF ASIA PACIFIC 149
9.5 LATIN AMERICA 153
9.6 MIDDLE EAST & AFRICA 156
10 COMPETITIVE LANDSCAPE 160
10.1 OVERVIEW 160
10.2 PRODUCT PORTFOLIO MATRIX 161
10.3 COMPETITIVE SITUATIONS AND TRENDS 162
10.3.1 PRODUCT LAUNCHES 163
10.3.2 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 163
10.3.3 ACQUISITIONS 164
10.3.4 EXPANSIONS 165
11 COMPANY PROFILES 167
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 DANAHER CORPORATION 167
11.2 THERMO FISHER SCIENTIFIC 170
11.3 PERKINELMER 174
11.4 AGILENT TECHNOLOGIES 178
11.5 BIO-RAD LABORATORIES 182
11.6 BECTON, DICKINSON AND COMPANY 186
11.7 ILLUMINA 189
11.8 F. HOFFMANN-LA ROCHE 192
11.9 FLUIDIGM CORPORATION 194
11.10 DOLOMITE MICROFLUIDICS 197
11.11 QIAGEN 204
11.12 ABBOTT LABORATORIES 207
11.13 BIOMÉRIEUX 210
11.14 MICROFLUIDIC CHIPSHOP 213
11.15 ELVEFLOW 214
11.16 CELLIX 215
11.17 MICRONIT MICROTECHNOLOGIES 216

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
12 APPENDIX 217
12.1 INSIGHTS OF INDUSTRY EXPERTS 217
12.2 DISCUSSION GUIDE 218
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 222
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 224
12.5 AVAILABLE CUSTOMIZATIONS 226
12.6 RELATED REPORTS 227
12.7 AUTHOR DETAILS 228

Shibuya data count

Shibuya Data Count is a reseller offering a variety of market research reports from different industries, provided by a global team of experienced research professionals who ensure the most reliable and up-to-date research analysis reports.

Recommended reports

+